Sponsored
8% DIVIDEND OPPORTUNITY ENDS TOMORROW
By the year 2027, 50% of knee replacement surgeries will be robotic – up from 12% today. Monogram (Nasdaq: MGRM) [4], known for its autonomous robotic surgical systems, just filed for FDA approval to commercialize their patented tech.